Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017

Abstract

Background & Aims Pancreatic cancer is a leading cause of cancer mortality and mortality has not decreased in recent years. We sought to determine global trends in pancreatic cancer mortality. Methods We derived data on deaths from pancreatic cancer from the World Health Organization database for 59 countries, from 1980 through 2013. Age-standardized mortalities were computed for persons of all ages and for persons 35–64 years old; for selected countries, they were computed for persons 25–49 years old. Joinpoint regression models were used to identify significant changes in mortality. For selected larger countries, we predicted numbers of deaths and mortality for 2017. Results Between 1980 and 2013, overall pancreatic cancer mortality in men increased in the European Union (EU), as well as in southern and eastern Europe, Brazil, Japan, and Republic of Korea. Overall pancreatic cancer mortality decreased in most northern European countries, Australia, Canada, Mexico, and the United States (US). In women, mortality increased in the EU, Brazil, US, Japan, and Republic of Korea but decreased in Canada and Mexico. In 2012, Eastern Europe and Japan had the highest pancreatic cancer mortality, for both sexes. In men 25–49 years old, mortality decreased in the EU, US, Japan, and most large European countries. Based on our data, we predict overall pancreatic cancer mortality in 2017 to level off in men in the EU and US, but increase in Japan. In women, mortality will continue to increase in most countries except the US; the greatest increase is predicted to occur in Japan. Conclusions Mortality from pancreatic cancer has not decreased as it has for other cancers in recent years. A notable exception is a decrease in mortality in men 25–49 years old, which could indicate a reversal in the current increasing global trends.

European cancer mortality predictions for the year 2019 with focus on breast cancer

“…Pancreatic cancer is the major site not showing favourable trends in recent years; in men the predicted trend reaches a plateau, in women it has still been rising; only in young men some declines were registered [27]. This probably reflects the different trends in smoking, the main recognized risk factor for this neoplasm, in the two sexes.…”

Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling

“…1 Although the incidence of pancreatic cancer has increased recently, the survival rate has not improved significantly. 2 Surgical resection is the only curative treatment for pancreatic cancer, but the surgical excision rate is less than 20% due to poor early diagnosis. 3 Therefore, a better understanding of the molecular mechanisms governing pancreatic cancer carcinogenesis is required for the prevention, early diagnosis and treatment of pancreatic cancer.…”

Genomics in Primary and Secondary Prevention of Pancreatic Cancer

“…In Europe, while mortality rates for all cancers fall, rising PC death rates have been observed [4,5] . This first observation was more evident among women in subsequent reports [6,7] . A recent publication estimated that, by 2017, there will be more deaths from PC than breast cancer in the EU [8] .…”